IDV vehicle
SPE2D224D0008
4610114675!PHARM MANUF/DISTR DIV - FSA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DLA TROOP SUPPORT |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $5.9M |
| Start date | Sep 27, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 4, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2025 | P00002 | $0 | 4610114675! |
| May 1, 2025 | P00001 | $0 | 4610114675!PHARM MANUF/DISTR DIV - FSA |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Nancy Fernandez | Contact | nancy.fernandez@dla.mil 215-737-4955 | Source | Oct 30, 2024 |
| Catherine Gilbert | Contact | catherine.gilbert@dla.mil 215-737-4778 | Source | Oct 30, 2024 |
| Nancy Fernandez | Contact | nancy.fernandez@dla.mil 215-737-4955 | Source | Apr 24, 2024 |
| Catherine Gilbert | Contact | catherine.gilbert@dla.mil 215-737-4778 | Source | Apr 24, 2024 |
| Nancy Fernandez | Contact | nancy.fernandez@dla.mil 215-737-4955 | Source | Mar 25, 2024 |
| Catherine Gilbert | Contact | catherine.gilbert@dla.mil 215-737-4778 | Source | Mar 25, 2024 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.